The Latest in Breast Cancer Clinical Trials

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

🌑 Deep Space Ocean Waves | 8 Hours of Peaceful Piano with Ocean Waves & Deep Space Ambience for Healing REM Sleep 🌊 8h 56m · 20 Sep 2026 · 8 Hour Sleep Music

Commentary Box: Andrew Saville and Jason Pine discuss the Warriors finals exit, NZ Rugby's financial woes 11 min · 20 Sep 2026 · The Mike Hosking Breakfast

"It was everything we love about footy." | First Thoughts - Hawthorn vs Brisbane (21.09.26) 16 min · 20 Sep 2026 · SEN Breakfast

What does global leadership on AI look like? 11 min · 20 Sep 2026 · Consider This from NPR

Full Show Podcast: 21 September 2026 1h 30m · 20 Sep 2026 · The Mike Hosking Breakfast

MORNING TEA: Emily In Paris Comes To An End & The Channing Tatum Burner Account Chaos 8 min · 20 Sep 2026 · The Spill

Report any issue

Source

Recorded12 Nov 2020

Publisherfeeds.buzzsprout.com

Handlerec:1648355

Show notes

Jame Abraham, MD, Chair of the Department of Hematology and Medical Oncology at the Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the latest in breast cancer clinical trials. Listen as Dr. Abraham shares his insight on how to get the word out to patients about clinical trials, the role COVID-19 has played in trial logistics, along with which trials he thinks are likely to have the biggest impact in how we treat patients with breast cancer.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in